Module

An HIV-1–Specific Microbicide Is a Public Health Priority

Source: HIV/AIDS Annual Update 2007

An HIV-1–Specific Microbicide Is a Public Health Priority

Faculty:
John P. Moore, PhD

CME CREDIT INFORMATION

Release Date: 07/02/07

Expiration Date: 07/01/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the mechanism of action of several investigational microbicides
Specify the practical and desired characteristics of microbicides
Discuss future directions in the design and application of microbicides

Topics covered include:

Introduction
Transmission of HIV-1 by Sexual Intercourse
A Successful Microbicide Must Be a Practical Microbicide
Reverse Transcriptase Inhibitor–Based Microbicides
HIV-1 Fusion/Entry as a Target for Microbicide Development
The Rationale for Using Entry Inhibitors in Combination
Modified-Release Delivery Systems: Toward a Practical Microbicide
Combining Prevention Strategies
Summary—Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.